Literature DB >> 29730746

Association of Parkinson's disease with industry sectors: a French nationwide incidence study.

Tim Vlaar1,2, Sofiane Kab2, Yannick Schwaab1, Nadine Fréry1, Alexis Elbaz1,2, Frédéric Moisan3.   

Abstract

In order to identify working environments at risk for Parkinson's disease (PD), we investigated the relation between the importance of industry sectors, used as a surrogate for occupational exposures, and PD incidence in French cantons. The number of incident PD cases (2010-2014) in 3689 cantons of metropolitan France was determined using drug claims from French National Health Insurance databases. The proportions of workers in 38 industry sectors in 2006 were calculated for each canton. Associations between the proportions of workers in industry sectors and PD age/sex-standardized incidence ratios were examined using incidence rate ratios (IRR) and 95% confidence intervals (CI) estimated with multilevel negative binomial regressions with a random intercept at the canton-level and adjusted for smoking, deprivation index, and density of neurologists. We then used two-step semi-Bayes hierarchical regression (HR) to include prior information about exposure to pesticides, metals, and solvents in each industry sector. We identified 112,625 incident cases. PD incidence was higher in areas characterized by high proportions of workers in "Agriculture, forestry and fishing" (IRRHR = 1.042; CI 95% = 1.014-1.070; p-TrendHR = 0.004), "Manufacture of textiles, wearing apparel, leather and related products" (IRRHR = 1.024; CI 95% = 1.005-1.044; p-TrendHR = 0.010), and "Manufacture of basic metals and fabricated metal products, except machinery and equipment" (IRRHR = 1.024; CI 95% = 1.003-1.046; p-TrendHR = 0.071). This nationwide study, based on a comprehensive analysis of industry sectors, shows significant associations between high proportions of workers in specific industry sectors (agriculture, metallurgy, textile) and PD incidence that may be targeted in further epidemiological studies to replicate and better understand these associations.

Entities:  

Keywords:  Environment; Epidemiology; Incidence; Industry sectors; Parkinson’s disease

Mesh:

Substances:

Year:  2018        PMID: 29730746     DOI: 10.1007/s10654-018-0399-3

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  32 in total

1.  A semi-Bayes approach to the analysis of correlated multiple associations, with an application to an occupational cancer-mortality study.

Authors:  S Greenland
Journal:  Stat Med       Date:  1992-01-30       Impact factor: 2.373

2.  Familial aggregation of Parkinson's disease: a meta-analysis.

Authors:  Evan L Thacker; Alberto Ascherio
Journal:  Mov Disord       Date:  2008-06-15       Impact factor: 10.338

3.  Education and occupations preceding Parkinson disease: a population-based case-control study.

Authors:  R Frigerio; A Elbaz; K R Sanft; B J Peterson; J H Bower; J E Ahlskog; B R Grossardt; M de Andrade; D M Maraganore; W A Rocca
Journal:  Neurology       Date:  2005-11-22       Impact factor: 9.910

4.  Software for hierarchical modeling of epidemiologic data.

Authors:  J S Witte; S Greenland; L L Kim
Journal:  Epidemiology       Date:  1998-09       Impact factor: 4.822

Review 5.  When does Parkinson disease start?

Authors:  Rodolfo Savica; Walter A Rocca; J Eric Ahlskog
Journal:  Arch Neurol       Date:  2010-07

6.  Gender differences in occupational exposure patterns.

Authors:  Amanda Eng; Andrea 't Mannetje; Dave McLean; Lis Ellison-Loschmann; Soo Cheng; Neil Pearce
Journal:  Occup Environ Med       Date:  2011-04-12       Impact factor: 4.402

7.  Occupation and parkinsonism in three movement disorders clinics.

Authors:  S M Goldman; C M Tanner; C W Olanow; R L Watts; R D Field; J W Langston
Journal:  Neurology       Date:  2005-09-14       Impact factor: 9.910

Review 8.  Endotoxin exposure and lung cancer risk: a systematic review and meta-analysis of the published literature on agriculture and cotton textile workers.

Authors:  Virissa Lenters; Ioannis Basinas; Laura Beane-Freeman; Paolo Boffetta; Harvey Checkoway; David Coggon; Lützen Portengen; Malcolm Sim; Inge M Wouters; Dick Heederik; Roel Vermeulen
Journal:  Cancer Causes Control       Date:  2009-12-12       Impact factor: 2.506

9.  Hierarchical regression for multiple comparisons in a case-control study of occupational risks for lung cancer.

Authors:  Marine Corbin; Lorenzo Richiardi; Roel Vermeulen; Hans Kromhout; Franco Merletti; Susan Peters; Lorenzo Simonato; Kyle Steenland; Neil Pearce; Milena Maule
Journal:  PLoS One       Date:  2012-06-11       Impact factor: 3.240

Review 10.  Meta-analysis of early nonmotor features and risk factors for Parkinson disease.

Authors:  Alastair J Noyce; Jonathan P Bestwick; Laura Silveira-Moriyama; Christopher H Hawkes; Gavin Giovannoni; Andrew J Lees; Anette Schrag
Journal:  Ann Neurol       Date:  2012-10-15       Impact factor: 10.422

View more
  15 in total

1.  Aminochrome Induces Neuroinflammation and Dopaminergic Neuronal Loss: A New Preclinical Model to Find Anti-inflammatory and Neuroprotective Drugs for Parkinson's Disease.

Authors:  Fillipe Mendes De Araújo; Annyta Fernandes Frota; Lívia Bacelar de Jesus; Ticiane Caribe Macedo; Lorena Cuenca-Bermejo; Consuelo Sanchez-Rodrigo; Kariny Maria Silva Ferreira; Juciele Valéria Ribeiro de Oliveira; Maria de Fatima Dias Costa; Juan Segura-Aguilar; Silvia Lima Costa; Maria Trinidad Herrero; Victor Diógenes Amaral Silva
Journal:  Cell Mol Neurobiol       Date:  2022-01-06       Impact factor: 5.046

2.  Association between Statin Use and Risk of Parkinson's Disease: Evidence from 18 Observational Studies Comprising 3.7 Million Individuals.

Authors:  Chieh-Chen Wu; Md Mohaimenul Islam; An-Jen Lee; Chun-Hsien Su; Yung-Ching Weng; Chih-Yang Yeh; Hsun-Hua Lee; Ming-Chin Lin
Journal:  J Pers Med       Date:  2022-05-19

3.  Well Water and Parkinson's Disease in Medicare Beneficiaries: A Nationwide Case-Control Study.

Authors:  Maya R Silver; Brad A Racette; Umber Dube; Irene M Faust; Susan Searles Nielsen
Journal:  J Parkinsons Dis       Date:  2020       Impact factor: 5.568

Review 4.  Role of Microgliosis and NLRP3 Inflammasome in Parkinson's Disease Pathogenesis and Therapy.

Authors:  Fillipe M de Araújo; Lorena Cuenca-Bermejo; Emiliano Fernández-Villalba; Silvia L Costa; Victor Diogenes A Silva; Maria Trinidad Herrero
Journal:  Cell Mol Neurobiol       Date:  2021-01-02       Impact factor: 5.046

Review 5.  Parkinson's Disease in Women and Men: What's the Difference?

Authors:  Silvia Cerri; Liudmila Mus; Fabio Blandini
Journal:  J Parkinsons Dis       Date:  2019       Impact factor: 5.568

Review 6.  Using induced pluripotent stem cells for modeling Parkinson's disease.

Authors:  Minjing Ke; Cheong-Meng Chong; Huanxing Su
Journal:  World J Stem Cells       Date:  2019-09-26       Impact factor: 5.326

7.  Objectives, design and main findings until 2020 from the Rotterdam Study.

Authors:  M Arfan Ikram; Guy Brusselle; Mohsen Ghanbari; André Goedegebure; M Kamran Ikram; Maryam Kavousi; Brenda C T Kieboom; Caroline C W Klaver; Robert J de Knegt; Annemarie I Luik; Tamar E C Nijsten; Robin P Peeters; Frank J A van Rooij; Bruno H Stricker; André G Uitterlinden; Meike W Vernooij; Trudy Voortman
Journal:  Eur J Epidemiol       Date:  2020-05-04       Impact factor: 8.082

8.  Solvent exposed occupations and risk of Parkinson disease in Finland.

Authors:  Susan Searles Nielsen; Mark N Warden; Markku Sallmén; Markku Sainio; Sanni Uuksulainen; Harvey Checkoway; Christer Hublin; Brad A Racette
Journal:  Clin Park Relat Disord       Date:  2021-04-20

9.  Global, regional, and national burden of Parkinson's disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.

Authors: 
Journal:  Lancet Neurol       Date:  2018-10-01       Impact factor: 44.182

10.  The PARK2 Mutation Associated with Parkinson's Disease Enhances the Vulnerability of Peripheral Blood Lymphocytes to Paraquat.

Authors:  Fengyu Ming; Jieqiong Tan; Lixia Qin; Hainan Zhang; Jianguang Tang; Xuling Tan; Chunyu Wang
Journal:  Biomed Res Int       Date:  2020-09-21       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.